Rubi Ghazala, MSc, MPhil, PhD, has 21 years of experience in Molecular Diagnostics. Her role involves molecular diagnostic planning, designing and new tests development with marketing along with pre commissioning and post commissioning. She is working on a project "Genetic Susceptibility of HCV in Ethnic groups of Pakistan". As a Molecular Pathologist, she established outreach clinical lab of AKUH in central Punjab region to cater the services for Punjab, North Punjab, KPK as well as Gilgit and remote areas. In this way, the business from North Punjab and KPK has been shifted to Lahore rather Karachi by this volume growth of molecular services has been reached to 27%. She developed and directly monitored the overall operations of the Clinical Molecular Laboratory. She supervises technical and non-technical staff. She was directly responsible for the startup of new molecular testing, technology evaluation, QA/QC, budget planning, equipment purchasing, and marketing along with lab administration, staff training, IQC training to staff, ISO audit, JCIA audit and PHC registration. The main focus of this molecular laboratory is to provide timely and accurate reporting of results and patient care. The laboratory is staffed for full consultation in all areas of molecular pathology and genetic testing. She actively participates in national and international CME and presented in more than 15 international conferences Rubi Ghazala, MSc, MPhil, PhD, has 21 years of experience in Molecular Diagnostics. Her role involves molecular diagnostic planning, designing and new tests development with marketing along with pre commissioning and post commissioning. She is working on a project "Genetic Susceptibility of HCV in Ethnic groups of Pakistan". As a Molecular Pathologist, she established outreach clinical lab of AKUH in central Punjab region to cater the services for Punjab, North Punjab, KPK as well as Gilgit and remote areas. In this way, the business from North Punjab and KPK has been shifted to Lahore rather Karachi by this volume growth of molecular services has been reached to 27%. She developed and directly monitored the overall operations of the Clinical Molecular Laboratory. She supervises technical and non-technical staff. She was directly responsible for the startup of new molecular testing, technology evaluation, QA/QC, budget planning, equipment purchasing, and marketing along with lab administration, staff training, IQC training to staff, ISO audit, JCIA audit and PHC registration. The main focus of this molecular laboratory is to provide timely and accurate reporting of results and patient care. The laboratory is staffed for full consultation in all areas of molecular pathology and genetic testing. She actively participates in national and international CME and presented in more than 15 international conferences

Gastroenterology